Blog

After months of waiting and working hand in hand with the competent authorities, on Monday October 19th the week opened with excellent news: the Ministry of Agriculture of Ecuador issued the regulations that govern the medical and industrial cannabis sector in the country. Although it may seem a little late in comparison with its neighbor […]

Last week, Colombian LP Clever Leaves proudly announced they received Colombia’s first EU-GMP certification to produce Active Pharmaceutical Ingredients (API), thus placing Colombian production one step closer to international exports. Leading position The news was received by the industry as a complete game-changer and glimpse of hope, not only because of the current global halt,

Jim Belushi says that before you have a cannabis company you have to have a compliance company. And we couldn’t agree more. In a hyper-regulated industry such as cannabis, it is vital that the regulations established by the entities that exercise control and monitoring are scrupulously followed. In Colombia, most of the licensed companies do

The Shock The cannabis stock crash of 2019 combined with the current public health situation has brought the global cannabis sector to an unprecedented situation: access to fresh capital is scarce. Companies in need of capital will need to adapt to this new reality by re-shaping its value proposition and convincing investors of their unique

The launch of the MICC (Information Mechanism for the Control of Cannabis) was always an imminent reality for the cannabis sector, as was the amendment to Decree 613/17. The face of hope With the grueling response times in the licensing process sometimes exceeding twelve months, the MICC is a hopeful ray of light for many,

URUGUAY In Uruguay, the regulation is complete and covers everything from industrial use to recreational use. However, the implementation of the standard and the development of capacities and knowledge of public institutions have been obstacles for the industry. Even with the newly positioned government, the industry does not see possibilities for a regressive orientation, as

Expectations vs. reality Sources consulted at the Colombian Agricultural Institute (ICA) confirm that the institute expects an avalanche of PEAs (Agronomic Evaluation Tests) by 2020. The vast majority will focus on non-psychoactive cannabis varieties, since the delay accumulated in the Ministry of Health to process applications for cannabis processing licenses has many companies waiting for

A halt in the cannabis rush Cannabis stocks had an intense year in 2019. During Q1, most listed companies reached all time highs on rosy revenue projections for the fiscal year. But since March, most blue-chips have dropped an average of 60-70%. Realized revenues were far from what investors expected. More than one CEO was

Hemp Today´s conference in Montevideo in November hosted the industry’s most active players in Latin America. 613 Partner’s delegation came back with the latest on legislative developments around the continent, innovative angles to monetizing hemp projects from the get-go, and a wide collection of exciting new partnerships prospects. A breakdown of what to look out

Our shining star The medical cannabis sector has been the star of 2019 in Colombia. Hundreds of articles have been written describing the medicinal benefits of the plant, the economic impact that the industry will bring to the country and the interest of foreign investors in the competitive advantages that Colombia presents to become a